SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 194.79+1.3%Dec 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DrJerry who wrote (13440)1/17/1998 10:42:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
DrJerry, I agree that the word is not getting out as quickly as I would like. Having LLY as a partner might help because I do think that they will be jumping on board with both feet because the market is huge and they really need to fill the hole that will be left when blockbusters like Prozac go off patent in 2002.

So far, Targretin Type II diabetes trials have only been done in Europe and when the US trials start, more research centers should be aware of Targretin and 2nd generation Rexinoids. It is pretty sad to see that an internet search of "Rexinoid" brings up only my posts and pages.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext